ArticleBlood advances2022

Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors.

Ella R Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.